Production (Stage)
Deltex Medical Group plc
DTXMF
$0.0952
$0.09223,073.33%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 42.65% | 42.21% | 1.25% | 4.91% | -42.73% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 42.65% | 42.21% | 1.25% | 4.91% | -42.73% |
| Cost of Revenue | -1.71% | -2.02% | 7.48% | 11.34% | 0.40% |
| Gross Profit | 78.39% | 77.88% | -1.56% | 1.99% | -57.45% |
| SG&A Expenses | 10.79% | 10.45% | -19.03% | -16.09% | -42.99% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 112.44% | 112.44% | -- | -- | -240.25% |
| Total Operating Expenses | 44.30% | 43.85% | 2.83% | 6.55% | -38.66% |
| Operating Income | -48.65% | -48.27% | -6.82% | -10.66% | 24.32% |
| Income Before Tax | -72.91% | -72.35% | -2.65% | -6.39% | -63.02% |
| Income Tax Expenses | -- | -- | -- | -- | 0.00% |
| Earnings from Continuing Operations | -73.14% | -72.60% | -2.47% | -6.20% | -63.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -73.14% | -72.60% | -2.47% | -6.20% | -63.15% |
| EBIT | -48.65% | -48.27% | -6.82% | -10.66% | 24.32% |
| EBITDA | -57.79% | -53.50% | -7.17% | -11.04% | 30.23% |
| EPS Basic | -33.33% | -33.33% | 60.00% | 60.00% | 25.00% |
| Normalized Basic EPS | 0.00% | 0.00% | 66.67% | 66.67% | 66.67% |
| EPS Diluted | -33.33% | -33.33% | 60.00% | 60.00% | 25.00% |
| Normalized Diluted EPS | 0.00% | 0.00% | 66.67% | 66.67% | 66.67% |
| Average Basic Shares Outstanding | 14.24% | 14.24% | 169.04% | 169.04% | 137.43% |
| Average Diluted Shares Outstanding | 14.24% | 14.24% | 169.04% | 169.04% | 137.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |